-
Add to Cart The item has been addedN655886-1mlNCT-502 (C007B-379244)
Price: $127.90List Price: $142.12NCT-502 is a human phosphoglycerate dehydrogenase ( PHGDH ) inhibitor, cytotoxic to PHGDH-dependent cancer cells, and reduces glucose-derived serine production, with an IC 50 of 3.7 μM against PHGDHIn VitroNCT-502 is cytotoxic to MDA-MB-468, with an -
Add to Cart The item has been added19718-10NCT-503-10 mg
Price: $376.35List Price: $418.17A PHGDH inhibitor that blocks serine synthesis from 3-phosphoglycerate in cells (IC<sub>50</sub> = 2.5 µM) reduces the production of glucose-derived serine in cells and suppresses the growth of PHGDH-dependent MDA-MB-468 cancer cells both in -
Add to Cart The item has been addedN413880-100mgNSC12 (C007B-392204)
Price: $1,848.97List Price: $2,054.42InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN413880-10mgNSC12 (C007B-392205)
Price: $330.86List Price: $367.63InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN413880-1mgNSC12 (C007B-392206)
Price: $61.80List Price: $68.67InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN413880-25mgNSC12 (C007B-392207)
Price: $594.61List Price: $660.68InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN413880-50mgNSC12 (C007B-392208)
Price: $1,068.93List Price: $1,187.70InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN413880-5mgNSC12 (C007B-392209)
Price: $195.10List Price: $216.78InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been addedN420386-1mlNSC12 (C007B-392388)
Price: $312.66List Price: $347.40InformationNSC12 NSC12 (NSC 172285) is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.TargetsFGF3 (Cell-free assay): FGF8b (Cell-free assay): FGF22 (Cell-free assay): FGF20 -
Add to Cart The item has been added30296530Pan SST Square Scout
Price: $56.00List Price: $62.22Pan SST Square Scout -
Add to Cart The item has been addedB5074-5 mgPan-HER (VEGFR/EGFR) inhibitor. It induces cell cycle arrest and inhibits growth of head and neck squamous cell carcinoma cells. (C003B-255878)
Price: $798.19List Price: $886.88BMS-599626 is a pan-HER inhibitor (including EGFR and VEGFR) that is currently in clinical trials as a potential treatment against several forms of cancer. BMS-599626 displays anticancer chemotherapeutic activity. -
Add to Cart The item has been addedB5074-10 mgPan-HER (VEGFR/EGFR) inhibitor. It induces cell cycle arrest and inhibits growth of head and neck squamous cell carcinoma cells. (C003B-256041)
Price: $1,253.68List Price: $1,392.97BMS-599626 is a pan-HER inhibitor (including EGFR and VEGFR) that is currently in clinical trials as a potential treatment against several forms of cancer. BMS-599626 displays anticancer chemotherapeutic activity.
